Updates on 503A Compounding: The Impact of Drug Shortages
The FDA’s temporary Guidance for 503A compounding of shortage drugs was meant to be temporary and withdrawn once COVID-19 ended.
Source: pharmacytimes.com
Stay updated with breaking news from Effect Guidance. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The FDA’s temporary Guidance for 503A compounding of shortage drugs was meant to be temporary and withdrawn once COVID-19 ended.